Piqur Therapeutics AG

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc

Historically, few biopharms have focused on kinase R&D. Sugen Inc. , the granddaddy of them all, generated all its considerable value well over a decade after it was acquired by Pharmacia Corp.

The U.K. biotech sector likes to talk up its leading position among European countries in terms of funds raised and products in development, but Britain’s lead isn’t all that secure - recent data from